BRENNAN DANIEL 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 4, 2019
Insider Transaction Report
Form 4
BRENNAN DANIEL
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2019-12-02+44,000→ 691,000 total→ Common Stock (44,000 underlying) - Award
Options to purchase common stock
2019-12-02+132,000→ 647,000 totalExercise: $4.64Exp: 2026-12-02→ Common Stock (132,000 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.